GOLDSMITH MARK A bought RVMD
April 15, 2026 · Form 4 insider transaction
GOLDSMITH MARK A bought 23,244 shares of Revolution Medicines, Inc. at $4.09 per share, a transaction worth $95.1K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
23,244
Price
$4.09
Total value
$95.1K
InsiderGOLDSMITH MARK A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateApril 15, 2026
Filing dateApril 17, 2026
Shares owned after299,942
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Transaction made pursuant to a 10b5-1 trading plan adopted by Mark A. Goldsmith on December 19, 2024.; Includes 201,150 restricted stock units.